References

1. American Cancer Society. Colorectal Cancer Facts and Figures Special Edition. Atlanta: American Cancer Society; 2008.

2. Jackson-Thompson J, Ahmed F, German RR, Lai SM, Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer 2006;107:1103-11. [PMID: 16835911]

3. Chu KC, Tarone RE, Chow WH, Alexander GA. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med 1995;4:849-56. [PMID: 7551132]

4. Cooper GS, Yuan Z, Rimm AA. Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev 1997;6:283-5. [PMID: 9107433]

5. Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 2000;31:447-53. [PMID: 11006071]

6. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999;85:1670-6. [PMID: 10223559]

7. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93. [PMID: 15061598]

8. Surveillance, Epidemiology, and End Results Program. Contents of the SEER Cancer Statistics Review, 1975-2003. Accessed at http://seer.cancer.gov/csr/1975_2003/#contents on 16 October 2006.

9. U.S. Preventive Services Task Force. Clinical Guide to Preventive Services, 2nd ed. Rockville, MD: Agency for Healthcare Research and Quality; 1996.

10. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007:CD001216. [PMID: 17253456]

11. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-41. [PMID: 12118972]

12. U.S. Preventive Services Task Force. Screening for colorectal cancer. In: Pocket Guide to Clinical Preventive Services, 2007: Recommendations of the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2007:32-5.

13. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104. [PMID: 12118964]

14. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31. [PMID: 12118971]

15. Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med 2003;36:352-62. [PMID: 12634026]

16. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-94. [PMID: 16492934]

17. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13. [PMID: 11717331]

18. Yeazel MW, Church TR, Jones RM, Kochevar LK, Watt GD, Cordes JE, et al. Colorectal cancer screening adherence in a general population. Cancer Epidemiol Biomarkers Prev 2004;13:654-7. [PMID: 15066933]

19. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104. [PMID: 17392386]

20. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 2008;57:253-8. [PMID: 18340331]

21. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med 2007;167:258-64. [PMID: 17296881]

22. Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR. Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Preventing Chronic Disease [serial online]. 2006;3. Accessed at http://www.cdc.gov/pcd/issues/2006/apr/05_0120.htm on 22 September 2008.

23. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health 2006;60:202-7. [PMID: 16476748]

24. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659-69.

25. Whitlock EP, Lin J, Liles E, Beil TL, Fu R, O'Connor E, et al. Screening for colorectal cancer: an updated systematic review. Rockville, MD: Agency for Healthcare Research and Quality; 2008.

26. Whitlock EP, Lin JS, Chou R, Shekelle P, Robinson KA. Using existing systematic reviews in complex systematic reviews. Ann Intern Med 2008;148:776-82. [PMID: 18490690]

27. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005;142:635-50. [PMID: 15838071]

28. HAYES. Computed tomography colonography (virtual colonoscopy). Lansdale, PA: HAYES; 2006.

29. Blue Cross Blue Shield Association. Fecal DNA analysis for colorectal cancer screening. Accessed at http://www.bcbs.com/blueresources/tec/vols/21/21_06.html on August 17, 2006.

30. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-6. [PMID: 10493205]

31. Soares-Weiser K, Burch J, Duffy S, St John J, Smith S, Westwood M, et al. Diagnostic accuracy and cost-effectiveness of faecal occult blood tests used in screening for colorectal cancer: a systematic review. York, United Kingdom: Centre for Reviews and Dissemination, University of York; 2007.

32. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004;140:189-202. [PMID: 14757617]

33. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al.Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20:21-35. [PMID: 11306229]

34. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. [PMID: 12111919]

35. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med 2000;19:3417-32. [PMID: 11122505]

36. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol 2008;61:41-51. [PMID: 18083461]

37. Blue Cross Blue Shield Association. Immunochemical versus guaiac fecal occult blood tests. Accessed at http://www.bcbs.com/tec/vol19/19_05.html on 17 August 2006.

38. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70. [PMID: 17895475]

39. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9. [PMID: 8531970].

40. Cheng TI, Wong JM, Hong CF, Cheng SH, Cheng TJ, Shieh MJ, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc 2002;101:685-90. [PMID: 12517041]

41. Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen 1996;3:66-71. [PMID: 8849762]

42. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AV, Bouvier VM, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6. [PMID: 15700317]

43. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55. [PMID: 17310048]

44. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8. [PMID: 16083699]

45. Nakama H, Yamamoto M, Kamijo N, Li T, Wei N, Fattah AS, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology 1999;46:228-31. [PMID: 10228797]

46. Nakama H, Kamijo N, Abdul Fattah AS, Zhang B. Validity of immunological faecal occult blood screening for colorectal cancer: a follow up study. J Med Screen 1996;3:63-5. [PMID: 8849761]

47. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME.Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14. [PMID: 15616205]

48. Haug U, Hillebrand T, Bendzko P, Löw M, Rothenbacher D, Stegmaier C, et al. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults. Clin Chem 2007;53:787-90. [PMID: 17317884]

49. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191-200. [PMID: 14657426]

50. Macari M, Milano A, Lavelle M, Berman P, Megibow AJ. Comparison of time-efficient CT colonography with two- and three-dimensional colonic evaluation for detecting colorectal polyps. AJR Am J Roentgenol 2000;174:1543-9. [PMID: 10845478]

51. Macari M, Bini EJ, Jacobs SL, Naik S, Lui YW, Milano A, et al. Colorectal polyps and cancers in asymptomatic average-risk patients: evaluation with CT colonography. Radiology 2004;230:629-36. [PMID: 14739311]

52. Rex DK, Vining D, Kopecky KK. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointest Endosc 1999;50:309-13. [PMID: 10462648]

53. Johnson CD, Fletcher JG, MacCarty RL, Mandrekar JN, Harmsen WS, Limburg PJ, et al. Effect of slice thickness and primary 2D versus 3D virtual dissection on colorectal lesion detection at CT colonography in 452 asymptomatic adults. AJR Am J Roentgenol 2007;189:672-80. [PMID: 17715116]

54. Kim SH, Lee JM, Eun HW, Lee MW, Han JK, Lee JY, et al. Two- versus three-dimensional colon evaluation with recently developed virtual dissection software for CT colonography. Radiology 2007;244:852-64. [PMID: 17709833]

55. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17. [PMID: 18799557]

56. Pickhardt PJ, Nugent PA, Choi JR, Schindler WR. Flat colorectal lesions in asymptomatic adults: implications for screening with CT virtual colonoscopy. AJR Am J Roentgenol 2004;183:1343-7. [PMID: 15505301]

57. Pickhardt PJ. Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults. Radiology 2006;239:313-6. [PMID: 16641348]

58. Edwards JT, Mendelson RM, Fritschi L, Foster NM, Wood C, Murray D, et al. Colorectal neoplasia screening with CT colonography in average-risk asymptomatic subjects: community-based study. Radiology 2004;230:459-64. [PMID: 14688402]

59. Sosna J, Blachar A, Amitai M, Barmeir E, Peled N, Goldberg SN, et al. Colonic perforation at CT colonography: assessment of risk in a multicenter large cohort. Radiology 2006;239:457-63. [PMID: 16543590]

60. Jensch S, van Gelder RE, Venema HW, Reitsma JB, Bossuyt PM, Laméris JS, et al. Effective radiation doses in CT colonography: results of an inventory among research institutions. Eur Radiol 2006;16:981-7. [PMID: 16418863]

61. van Gelder RE, Venema HW, Serlie IW, Nio CY, Determann RM, Tipker CA, et al. CT colonography at different radiation dose levels: feasibility of dose reduction. Radiology 2002;224:25-33. [PMID: 12091658]

62. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Board on Radiation Effects, Research Division on Earth and Life Sciences, National Research Council of the National Academics. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII, Phase 2. Washington, DC: National Academies Press; 2006.

63. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 2007;298:317-23. [PMID: 17635892]

64. Ginnerup Pedersen B, Rosenkilde M, Christiansen TE, Laurberg S. Extracolonic findings at computed tomography colonography are a challenge. Gut 2003;52:1744-7. [PMID: 14633954]

65. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology 2000;215:353-7. [PMID: 10796907]

66. Pickhardt PJ, Kim DH, Taylor AJ, Gopal DV, Weber SM, Heise CP. Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography. Dis Colon Rectum 2007;50:56-63. [PMID: 17115333]

67. Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007;357:1403-12. [PMID: 17914041]

68. Chin M, Mendelson R, Edwards J, Foster N, Forbes G. Computed tomographic colonography: prevalence, nature, and clinical significance of extracolonic findings in a community screening program. Am J Gastroenterol 2005;100:2771-6. [PMID: 16393234]

69. Gluecker TM, Johnson CD, Wilson LA, Maccarty RL, Welch TJ, Vanness DJ, et al. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 2003;124:911-6. [PMID: 12671887]

70. Pickhardt PJ, Hanson ME, Vanness DJ, Lo JY, Kim DH, Taylor AJ et al. Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 2008;249:151-59.

71. Zalis ME, Barish MA, Choi JR, Dachman AH, Fenlon HM, Ferrucci JT, et al.Working Group on Virtual Colonoscopy. CT colonography reporting and data system: a consensus proposal [Editorial]. Radiology 2005;236:3-9. [PMID: 15987959]

72. Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560-5. [PMID: 9616321]

73. Cotterill M, Gasparelli R, Kirby E. Colorectal cancer detection in a rural community. Development of a colonoscopy screening program. Can Fam Physician 2005;51:1224-8. [PMID: 16190175]

74. Kewenter J, Brevinge H. Endoscopic and surgical complications of work-up in screening for colorectal cancer. Dis Colon Rectum 1996;39:676-80. [PMID: 8646956]

75. Ko CW, Riffle S, Morris CG, Michaels L, Holub JL, Shapiro J, et al. Complications after screening and surveillance colonoscopy [Abstract]. Gastroenterology 2007;132:A149.

76. Ko CW, Riffle S, Shapiro JA, Saunders MD, Lee SD, Tung BY, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc 2007;65:648-56. [PMID: 17173914]

77. Korman LY, Overholt BF, Box T, Winker CK. Perforation during colonoscopy in endoscopic ambulatory surgical centers. Gastrointest Endosc 2003;58:554-7. [PMID: 14520289]

78. Lee YC, Wang HP, Chiu HM, Lin CP, Huang SP, Lai YP, et al. Factors determining post-colonoscopy abdominal pain: prospective study of screening colonoscopy in 1000 subjects. J Gastroenterol Hepatol 2006;21:1575-80. [PMID: 16928219]

79. Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006;145:880-6. [PMID: 17179057]

80. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002;55:307-14. [PMID: 11868001]

81. Newcomer MK, Shaw MJ, Williams DM, Jowell PS. Unplanned work absence following outpatient colonoscopy. J Clin Gastroenterol 1999;29:76-8. [PMID: 10405238]

82. Rathgaber SW, Wick TM. Colonoscopy completion and complication rates in a community gastroenterology practice. Gastrointest Endosc 2006;64:556-62. [PMID: 16996349]

83. Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588-92. [PMID: 10486370]

84. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al.SCORE Working Group—Italy. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"—SCORE. J Natl Cancer Inst 2002;94:1763-72. [PMID: 12464648]

85. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414-20. [PMID: 10365903]

86. Betés Ibáñez M, Muñoz-Navas MA, Duque JM, Angós R, Macías E, Súbtil JC, et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc 2004;59:634-41. [PMID: 15114305]

87. Ikeda Y, Mori M, Miyazaki M, Yoshizumi T, Maehara Y, Sugimachi K. Significance of small distal adenoma for detection of proximal neoplasms in the colorectum. Gastrointest Endosc 2000;52:358-61. [PMID: 10968850]

88. Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, et al.CONCeRN Study Investigators. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8. [PMID: 15901859].

89. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8. [PMID: 10900274]

90. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 2003;139:959-65. [PMID: 14678915]

91. Anderson JC, Alpern Z, Messina CR, Lane B, Hubbard P, Grimson R, et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004;99:472-7. [PMID: 15056088]

92. Schoenfeld P, Lipscomb S, Crook J, Dominguez J, Butler J, Holmes L, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology 1999;117:312-8. [PMID: 10419911]

93. Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, et al.Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003;290:41-8. [PMID: 12837710]

94. Burke CA, Elder K, Lopez R. Screening for colorectal cancer with flexible sigmoidoscopy: is a 5-yr interval appropriate? A comparison of the detection of neoplasia 3 yr versus 5 yr after a normal examination. Am J Gastroenterol 2006;101:1329-32. [PMID: 16771957]

95. Jain A, Falzarano J, Jain A, Decker R, Okubo G, Fujiwara D. Outcome of 5,000 flexible sigmoidoscopies done by nurse endoscopists for colorectal screening in asymptomatic patients. Hawaii Med J 2002;61:118-20. [PMID: 12148407]

96. Levin TR, Conell C, Shapiro JA, Chazan SG, Nadel MR, Selby JV. Complications of screening flexible sigmoidoscopy. Gastroenterology 2002;123:1786-92. [PMID: 12454834]

97. Wallace MB, Kemp JA, Meyer F, Horton K, Reffel A, Christiansen CL, et al. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med 1999;107:214-8. [PMID: 10492313]

98. Viiala CH, Olynyk JK. Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal carcinoma. Med J Aust 2007;187:274-7. [PMID: 17767431]

99. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003;38:635-42. [PMID: 12825872]

100. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300. [PMID: 11965274]

101. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, et al. PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97. [PMID: 15998952]

102. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006;332:1089-92. [PMID: 16675820]

103. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 2006;144:850-5. [PMID: 16754927]

104. Centers for Medicare & Medicaid Services. 2008 clinical diagnostic laboratory fee schedule. Accessed at http://www.cms.hhs.gov/apps/ama/license.asp?file=/ClinicalLabFeeSched/downloads/08clab-b.zip on 17 June 2008.

105. Woolf SH. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer [Editorial]. N Engl J Med 2004;351:2755-8. [PMID: 15616212]

106. Decision Memo for Screening DNA Stool Test for Colorectal Cancer (CAG-00144N). Washington, DC: Centers for Medicare & Medicaid Services. Accessed at http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=212 on 28 April 2008.

107. U.S. Food and Drug Administration, U.S. Department of Health and Human Services. Warning Letter. 2007. Accessed at http://www.fda.gov/foi/warning_letters/s6568c.htm on 17 October 2007.

108. Guide to the clinical use of Pre-Gen Plus: Non-invasive colorectal cancer screening. Burlington, NC: Laboratory Corporation of America; 2003.

109. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al.American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60. [PMID: 18322143]

110. Graser A. Results from the "Munich Colorectal Cancer Prevention Trial": comparison of low-dose 64 MDCT colonography and video colonoscopy in a screening population [Abstract]. Radiological Society of North America Meeting; 28 November 2006.

111. Ransohoff DF. Virtual colonoscopy-what it can do vs what it will do. JAMA 2004;291:1772-74.

112. Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. [PMID: 18046031]

113. Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern? Gastroenterology 2005;129:328-37. [PMID: 16012958]

114. Liedenbaum MH, Venema HW, Stoker J. Radiation dose in CT colonography-trends in time and differences between daily practice and screening protocols. Eur Radiol 2008;18:2222-2230. [PMID: 18491095]

115. Hassan C, Pickhardt PJ, Pickhardt P, Laghi A, Kim DH, Kim D, et al. Computed tomographic colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis. Arch Intern Med 2008;168:696-705. [PMID: 18413551]

116. Fletcher RH, Pignone M. Extracolonic findings with computed tomographic colonography: asset or liability? [Editorial] Arch Intern Med 2008;168:685-6. [PMID: 18413549]

117. Kim DH, Pickhardt PJ, Hoff G, Kay CL. Computed tomographic colonography for colorectal screening. Endoscopy 2007;39:545-9. [PMID: 17554653]

118. Burling D, Halligan S, Altman DG, Atkin W, Bartram C, Fenlon H, et al. Polyp measurement and size categorisation by CT colonography: effect of observer experience in a multi-centre setting. Eur Radiol 2006;16:1737-44. [PMID: 16636803]

119. Young BM, Fletcher JG, Paulsen SR, Booya F, Johnson CD, Johnson KT, et al. Polyp measurement with CT colonography: multiple-reader, multiple-workstation comparison. AJR Am J Roentgenol 2007;188:122-9. [PMID: 17179354]

120. Yeshwant SC, Summers RM, Yao J, Brickman DS, Choi JR, Pickhardt PJ. Polyps: linear and volumetric measurement at CT colonography. Radiology 2006;241:802-11. [PMID: 17114627]

121. Halligan S, Taylor SA. CT colonography: results and limitations. Eur J Radiol 2007;61:400-8. [PMID: 17174055]

122. Burling D, Halligan S, Atchley J, Dhingsar R, Guest P, Hayward S, et al. CT colonography: interpretative performance in a non-academic environment. Clin Radiol 2007;62:424-9; discussion 430-1. [PMID: 17398266]

123. Barnes E. ACRIN trial shows VC ready for widespread use. 28 September 2007.Accessed at htpp://www.auntminnie.com/index.asp?Sec=sup&Sub=vco&Pag=dis&ItemId=77711 on 22 October 2007.

124. Pickhardt PJ, Taylor AJ, Kim DH, Reichelderfer M, Gopal DV, Pfau PR. Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 2006;241:417-25. [PMID: 16982816]

125. Rex DK. Virtual colonoscopy: time for some tough questions for radiologists and gastroenterologists [Editorial]. Endoscopy 2000;32:260-3. [PMID: 10718393].

126. Hara AK. The future of colorectal imaging: computed tomographic colonography. Gastroenterol Clin North Am 2002;31:1045-60. [PMID: 12489277]

127. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. ASGE/ACG Taskforce on Quality in Endoscopy Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873-85. [PMID: 16635231]

128. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50. [PMID: 16454841]

129. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007;132:96-102. [PMID: 17241863]

130. Pignone M. Screening for colorectal cancer in adults. Rockville, MD: Agency for Healthcare Research and Quality; 2002. AHRQ Publication No. 02-S003.

131. Rockey DC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005;365:305-11. [PMID: 15664225]

132. Banerjee S, Van Dam J. CT colonography for colon cancer screening. Gastrointest Endosc 2006;63:121-33. [PMID: 16377329]

133. CT colonography ("virtual colonoscopy") for colon cancer screening. Chicago: Blue Cross Blue Shield Association; 2004

134. Sosna J, Morrin MM, Kruskal JB, Lavin PT, Rosen MP, Raptopoulos V. CT colonography of colorectal polyps: a metaanalysis. AJR Am J Roentgenol 2003;181:1593-8. [PMID: 14627580]

135. National Institute of Health and Clinical Excellence. Computed tomographic colonography. National Institute of Health and Clinical Excellence: 2005. Report no. IPG129.

136. HAYES. Fecal DNA testing for colorectal cancer screening and monitoring. Lansdale, PA: HAYES; 2002.

137. Haug U, Brenner H. New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness. Int J Cancer 2005;117:169-76. [PMID: 15880368]

138. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004.

139. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991;44:1271-8. [PMID: 1834807]

140. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25. [PMID: 14606960]

Return to Contents
Proceed to Next Section